Canada: Toronto-based nanotechnology startup Mesosil has closed $2.2 million CAD in seed funding to ramp up its production and fuel its commercialization plans.

Spun out of the University of Toronto, Mesosil is developing nanometre-scale, silica-based additives designed to prevent infection and disease at the tissue-biomaterial level and extend the lifespan of dental and medical devices like fillers and implants.

After years of research and development, Mesosil has finalized its flagship material and the startup says it is ready to scale up production to meet customer demand in the dentistry space with fresh funding from deep tech-focused GreenSky Ventures and a group of other investors.